Incentive formularies and changes in prescription drug spending

American Journal of Managed Care

Volumn 13, Issue 6 II, 2007, Pages 360-369

  Landon, Bruce E ^a,b   Rosenthal, Meredith B ^c   Normand, Sharon Lise T ^a,c   Spettell, Claire ^e   Lessler, Adam ^a   Underwood, Howard R ^e   Newhouse, Joseph P ^a,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD UNIVERSITY   (United States)

^e AETNA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; CLINICAL PRACTICE; COST CONTROL; DRUG COST; DRUG FORMULARY; DRUG USE; HEALTH INSURANCE; MOTIVATION; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT;

ADULT; COHORT STUDIES; DEDUCTIBLES AND COINSURANCE; DRUG UTILIZATION REVIEW; FEMALE; FORMULARIES; HEALTH CARE SURVEYS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; PATIENT COMPLIANCE; PRESCRIPTION FEES; UNITED STATES;

EID: 34250868997     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. The Henry J. Kaiser Family Foundation. Prescription drug trends. November 2005. Available at: http://kff.org/insurance/upload/3057-04.pdf. Accessed March 28, 2007.
2. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clin Ther. 2003;25:3147-3161; discussion 3144-3146.
3. Gibson TB, McLaughlin CG, Smith DG. A copayment increase for prescription drugs: the long-term and short-term effects on use and expenditures. Inquiry. 2005;42:293-310.
4. Hillman AL, Pauly MV, Escarce JJ, et al. Financial incentives and drug spending in managed care. Health Aff (Millwood). 1999;18:189-200.
5. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003;349:2224-2232.
6. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002;288:1733-1739.
7. Lipton HL, Gross DJ, Stebbins MR, Syed LH. Managing the pharmacy benefit in Medicare HMOs: what do we really know? Health Aff (Millwood). 2000;19:42-58.
8. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001;39: 1293-1304.
9. Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS. Effect of tiered prescription copayments on the use of preferred brand medications. Med Care. 2003;41:398-406.
10. Stuart B, Zacker C. Who bears the burden of Medicaid drug copayment policies? Health Aff (Millwood). 1999;18:201-212.
11. Ash AS, Ellis RP, Pope GC, et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev. 2000;21:7-28.
12. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods: structure, distances, and algorithms. Journal of Computational and Graphical Statistics. 1993;2:405-420.
13. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-740.
14. Gleason PP, Gunderson BW, Gericke KR. Are incentive-based formularies inversely associated with drug utilization in managed care? Ann Pharmacother. 2005;39:339-345.
15. Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care. 2005;11:621-628.
16. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166:332-337.
17. Kamal-Bahl S, Briesacher B. How do incentive-based formularies influence drug selection and spending for hypertension? Health Aff (Millwood). 2004;23:227-236.
18. Motheral BR, Henderson R. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Am J Manag Care. 1999;5:1383-1394.
19. Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. J Manag Care Pharm. 2003;9:123-133.
20. Thomas CP, Wallack SS, Lee S, Ritter GA. Impact of health plan design and management on retirees' prescription drug use and spending, 2001. Health Aff (Millwood). 2002;Suppl Web Exclusives:W408-419.
21. Leibowitz A, Manning WG, Newhouse JP. The demand for prescription drugs as a function of cost-sharing. Soc Sci Med. 1985;21: 1063-1069.